2006;175:361 5. 69. Cameron A, Davis KB, Green G, et al. Coronary bypass surgery with internal-thoracic-artery grafts effects on survival over a 15-year period. N Engl J Med. 1996;334:216 9. 70. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal- mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1 6. 71. Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004;109:2290 5. 72. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352:2174 83. 73. Deleted in proof. 74. The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997;96:1761 9. 75. The BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49:1600 6. 76. Banning AP, Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: com- parison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55:1067 75. 77. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of ran- domized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol. 2003;41:1293 304. 78. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082 9. 79. Malenka DJ, Leavitt BJ, Hearne MJ, et al. 